by Dennis Crouch Documents: FedCir Vanda Decision; Vanda EnBanc Brief The Federal Circuit recently sided with the accused infringers Teva and Apotex, affirming the invalidation claims from four Vanda patents covering methods of using tasimelteon to treat circadian rhythm disorders. However, the patent owner has petitioned the court for en banc rehearing, arguing the panel improperly … Continue reading Federal Circuit’s Sleepy Obviousness Decision and Vanda’s En Banc Rehearing Petition